# Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study

> **NCT01934192** · PHASE2 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 91 (actual)

## Conditions studied

- Gastroparesis

## Interventions

- **DRUG:** GSK962040 50 mg
- **DRUG:** Metoclopramide 10 mg
- **DRUG:** Placebo NG
- **DRUG:** Placebo IV

## Key facts

- **NCT ID:** NCT01934192
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-04-04
- **Primary completion:** 2016-07-08
- **Final completion:** 2016-07-08
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2017-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01934192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01934192, "Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01934192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*